Balance Sheet
Cash Flow Statement
AmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for MediWound (MDWD) over the last 13 years, with Q3 2025 value amounting to $740000.0.

  • MediWound's Share-based Compensation fell 2925.43% to $740000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 3787.3%. This contributed to the annual value of $3.1 million for FY2024, which is 26175.26% up from last year.
  • According to the latest figures from Q3 2025, MediWound's Share-based Compensation is $740000.0, which was down 2925.43% from $862000.0 recorded in Q2 2025.
  • In the past 5 years, MediWound's Share-based Compensation ranged from a high of $1.0 million in Q3 2024 and a low of -$822000.0 during Q4 2024
  • Its 5-year average for Share-based Compensation is $256473.7, with a median of $390000.0 in 2021.
  • Examining YoY changes over the last 5 years, MediWound's Share-based Compensation showed a top increase of 23633.44% in 2024 and a maximum decrease of 37583.89% in 2024.
  • Quarter analysis of 5 years shows MediWound's Share-based Compensation stood at $390000.0 in 2021, then plummeted by 264.62% to -$642000.0 in 2022, then surged by 146.42% to $298000.0 in 2023, then tumbled by 375.84% to -$822000.0 in 2024, then surged by 190.02% to $740000.0 in 2025.
  • Its Share-based Compensation was $740000.0 in Q3 2025, compared to $862000.0 in Q2 2025 and $844000.0 in Q1 2025.